Dr. Sohi on why PSMA-PET results can alter treatment plans
In this video, Jaideep S. Sohi, MD, explains how the expanded information provided by PSMA-PET imaging allows physicians to more accurately tailor treatment plans for patients.
EP: 1.Harnessing the Full Power of PSMA-PET Requires Multidisciplinary Approach
EP: 2.Dr. Spratt on the importance of a multidisciplinary approach to PSMA-PET
EP: 3.PSMA-PET leads imaging breakthroughs in prostate cancer paradigm
EP: 4.Conventional imaging obstacles that PSMA-PET overcomes
EP: 5.Dr. Sohi on the timing of PSMA-PET imaging in prostate cancer
EP: 6.Dr. Sohi on why PSMA-PET results can alter treatment plans
In this video, Jaideep S. Sohi, MD, explains how the expanded information provided by PSMA-PET imaging allows physicians to more accurately tailor treatment plans for patients. Sohi is a nuclear medicine physician with Northwestern University and American Molecular Imaging.
Transcription
PSMA-PET imaging has allowed us to get a more accurate diagnosis. We are now able to evaluate the patient’s entire body. So we now have the ability to get a more accurate perspective on patients’ disease stage. We can tell for the most part if the disease is localized to the pelvis, or if it has spread to distant organs. Of course, with that knowledge knowing we are able to more accurately tailor the patient's treatment planning paradigm.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
